Rochester General Hospital Lipson Cancer Institute — Rochester, New York

Rochester General Hospital Lipson Cancer Institute is a clinical research site located in Rochester, New York, United States 14621.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

Rochester General Hospital Lipson Cancer Institute has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Multiple Myeloma, Breast Neoplasms.

Sponsors: Celgene, BioNTech SE.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rochester

Browse all research sites in New York · View every site in Rochester

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rochester General Hospital Lipson Cancer Institute?

Rochester General Hospital Lipson Cancer Institute has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rochester General Hospital Lipson Cancer Institute conducted?

Rochester General Hospital Lipson Cancer Institute has 2 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma, Breast Neoplasms.

Is Rochester General Hospital Lipson Cancer Institute accredited by Crixeo Clinical Trials?

Rochester General Hospital Lipson Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rochester General Hospital Lipson Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.